Results 21 to 30 of about 35,407 (190)

The diagnosis of metastatic uveal melanoma. What has changed during 10 years?

open access: yesAlʹmanah Kliničeskoj Mediciny, 2020
Uveal melanoma is the most common intraocular malignancy. Despite significant progress in the treatment of the primary tumor, uveal melanoma continues to be the most aggressive tumor due to its high potential for hematogenous metastatic spread.
E. E. Grishina   +2 more
doaj   +1 more source

The prognostic implication of latitude in uveal melanoma: a nationwide observational cohort study of all patients born in Sweden between 1947 and 1989

open access: yesDiscover Oncology, 2022
Background The incidence of uveal melanoma increases with latitude. In this study, we examine the importance of latitude for uveal melanoma prognosis. Methods All uveal melanoma patients born in Sweden between 1947 and 1990 were included (n = 745).
Gustav Stålhammar   +2 more
doaj   +1 more source

Immunological backbone of uveal melanoma: is there a rationale for immunotherapy? [PDF]

open access: yes, 2019
No standard treatment has been established for metastatic uveal melanoma (mUM). Immunotherapy is commonly used for this disease even though UM has not been included in phase III clinical trials with checkpoint inhibitors.
Alessandra Cassano   +24 more
core   +1 more source

Osteopontin and `Melanoma Inhibitory Activity': Comparison of Two Serological Tumor Markers in Metastatic Uveal Melanoma Patients [PDF]

open access: yes, 2009
Background: Evaluation of the protein osteopontin (OPN) as a potential new marker in comparison to melanoma inhibitory activity (MIA) for screening and detection of metastatic uveal melanoma. Methods: Plasma levels of 32 patients with uveal melanoma were
Haritoglou, Christos   +5 more
core   +1 more source

Epidemiology of uveal melanomas in Moscow

open access: yesAlʹmanah Kliničeskoj Mediciny, 2017
Rationale: Melanoma of the uveal tract of the eye is among the most prevalent malignant intraocular tumors.Aim: To identify epidemiological characteristics of uveal melanoma in Moscow.Materials and methods: We performed a retrospective analysis of out ...
E. E. Grishina   +2 more
doaj   +1 more source

MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression. [PDF]

open access: yesPLoS ONE, 2015
MicroRNAs (miRNAs) are a group endogenous small non-coding RNAs that inhibit protein translation through binding to specific target mRNAs. Recent studies have demonstrated that miRNAs are implicated in the development of cancer.
Lei Sun   +5 more
doaj   +1 more source

Transplantable melanomas in hamsters and gerbils as models for human melanoma : sensitization in melanoma radiotherapy : from animal models to clinical trials [PDF]

open access: yes, 2018
The focus of the present review is to investigate the role of melanin in the radioprotection of melanoma and attempts to sensitize tumors to radiation by inhibiting melanogenesis. Early studies showed radical scavenging, oxygen consumption and adsorption
Andrzej Słominski   +11 more
core   +1 more source

Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma

open access: yesMolecular Biomedicine, 2021
Here, we discuss the presence and roles of heterogeneity in the development of uveal melanoma. Both genetic and cellular heterogeneity are considered, as their presence became undeniable due to single cell approaches that have recently been used in uveal
Mark J. de Lange   +2 more
doaj   +1 more source

Features of effector lymphocyte subsets in patients with uveal melanoma in recurrent and chronic herpesvirus infection

open access: yesИнфекция и иммунитет, 2022
The aim of the study is to conduct a comparative analysis of percentages for peripheral blood effector lymphocyte subsets in patients with uveal melanoma manifested by recurrent and chronic herpesvirus infection.
N. V. Balatskaya   +4 more
doaj   +1 more source

Therapeutic applications of SAMMSON lncRNA inhibition in uveal melanoma [PDF]

open access: yes, 2017
Uveal melanoma is the most common intraocular malignancy in adults. The lack of an effective treatment results in a median survival time less than one year for patients with metastatic disease.
De Paepe, Boel   +7 more
core   +5 more sources

Home - About - Disclaimer - Privacy